Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospecti... by Goedkoop, Amber Y, Kraan, Maarten C, Picavet, Daisy I, de Rie, Menno A, Teunissen, Marcel B M, Bos, Jan D, Tak, Paul P

Get full text

Digital image analysis for the evaluation of the inflammatory infiltrate in psoriasis by GOEDKOOP, Amber Y, DE RIE, Menno A, TEUNISSEN, Marcel B. M, PICAVET, Daisy I, VAN DER HALL, Pascal O, BOS, Jan D, TAK, Paul P, KRAAN, Maarten C

Get full text

Alefacept therapy reduces the effector T-cell population in lesional psoriatic epidermis by Goedkoop, Amber Y, de Rie, Menno A, Picavet, Daisy I, Kraan, Maarten C, Dinant, Huib J, van Kuijk, Arno W R, Tak, Paul P, Bos, Jan D, Teunissen, Marcel B M

Get full text

Alefacept treatment in psoriatic arthritis: Reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of... by Kraan, Maarten C., van Kuijk, Arno W. R., Dinant, Huibert J., Goedkoop, Amber Y., Smeets, Tom J. M., de Rie, Menno A., Dijkmans, Ben A. C., Vaishnaw, Akshay K., Bos, Jan D., Tak, Paul P.

Get full text

Alefacept selectively reduces memory-effector (CD45RO+) T cells and improves clinical outcomes in psoriasis and psoriatic arthritis by Dinant, Huibert J, Kuijk, Arno WR Van, Goedkoop, Amber Y, Kraan, Maarten C, De Rie, Menno A, Dijkmans, Ben AC, Vaishnaw, Akshay K, Krueger, Gerald, Tak, Paul P

Get full text